TERMINATION OF PTH RESPONSES IN OSTEOBLASTS
TERMINATION OF PTH RESPONSES IN OSTEOBLASTS
批准号:
6762427
负责人:
EDWARD M. GREENFIELD
金额:
$28.31万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2007-07-31
关键词:
adenylate cyclaseantisense nucleic acidbeta adrenergic agentbeta adrenergic receptorbone developmentbone metabolismcyclic AMPenzyme activityenzyme induction /repressiongenetic regulationhormone regulation /control mechanismimmunofluorescence techniqueimmunoprecipitationinterleukin 6isoproterenolkinase inhibitorlaboratory ratosteoblastsosteoprotegerinparathyroid hormone related proteinparathyroid hormonesprotein kinase Areceptor sensitivitytissue /cell culturetranscription factorwestern blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): PTH and PTHrP are important regulators of calcium homeostasis and bone turnover in many diseases. Many of the effects of PTH, PTHrP, and other GPCR agonists on gene expression are transient. We have recently shown that the primary mechanism(s) responsible for termination of gene regulation following stimulation by PTH or ¿-adrenergic agonists is(are) downstream of receptor desensitization, adenyl cyclase activation, and cAMP degradation. PTH and ¿-adrenergic agonists also stimulate PKA activity and transcription factor phosphorylation in a transient fashion. Thus, it is likely that termination of PKA activity is responsible for termination of downstream events, including transcription factor phosphorylation and gene regulation. When overexpressed, protein kinase inhibitor (PKI) inactivates PKA. We therefore hypothesize that termination of PKA activity by PKI is primarily responsible for termination of gene regulation following stimulation by PTH or ¿-adrenergic agonists. Despite the large number of studies examining purified or overexpressed PKI, little is known about the physiological role of these molecules in cells. Our proposed experiments will be the first to determine whether endogenous levels of PKI are sufficient to reduce PKA activity or downstream gene regulation. Our specific aims are: 1) Test the hypothesis that endogenous PKI interacts with PKA following stimulation by PTH or isoproterenol; 2) Test the hypothesis that endogenous PKI is primarily responsible for termination of both PKA activity and gene regulation following stimulation by PTH or isoproterenol; 3) Test the hypothesis that termination of PTH-induced gene regulation by endogenous PKI is physiologically important. These experiments will substantially increase our understanding of the role of PKI in both PKA signaling and gene regulation in mesenchymal cells as well as the mechanisms responsible for balancing the catabolic effects of PTH. Our findings will also serve as paradigm for regulation of PKA signaling in other cell types.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of age-related bone loss by PKIgamma
-
批准号:10208697
-
项目类别:
-
资助金额:$41.1万
-
财政年份:2020
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
Regulation of age-related bone loss by PKIgamma
-
批准号:10399612
-
项目类别:
-
资助金额:$41.42万
-
财政年份:2020
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
Regulation of age-related bone loss by PKIgamma
-
批准号:10615740
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2020
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
P2X7R: a novel therapeutic target in implant loosening
-
批准号:9244951
-
项目类别:
-
资助金额:$16.72万
-
财政年份:2017
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
ERK Mitogen Activated Protein Kinases in Skeletogenesis
-
批准号:8118194
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2009
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
ERK Mitogen Activated Protein Kinases in Skeletogenesis
-
批准号:8289660
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2009
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
IN VIVO REGULATION OF cAMP/PKA SIGNALING BY PKIgamma
-
批准号:7297123
-
项目类别:
-
资助金额:$19.93万
-
财政年份:2007
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
IN VIVO REGULATION OF cAMP/PKA SIGNALING BY PKIgamma
-
批准号:7488497
-
项目类别:
-
资助金额:$16.3万
-
财政年份:2007
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
TERMINATION OF PTH RESPONSES IN OSTEOBLASTS
-
批准号:6926114
-
项目类别:
-
资助金额:$28.31万
-
财政年份:2003
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
TERMINATION OF PTH RESPONSES IN OSTEOBLASTS
-
批准号:6673072
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2003
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
TERMINATION OF PTH RESPONSES IN OSTEOBLASTS
-
批准号:7104895
-
项目类别:
-
资助金额:$27.64万
-
财政年份:2003
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
OSTEOCLAST DIFFERENTIATION BY MESENCHYMAL CELLS
-
批准号:6481780
-
项目类别:
-
资助金额:$25.17万
-
财政年份:2002
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
OSTEOCLAST DIFFERENTIATION BY MESENCHYMAL CELLS
-
批准号:6891953
-
项目类别:
-
资助金额:$21.96万
-
财政年份:2002
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
OSTEOCLAST DIFFERENTIATION BY MESENCHYMAL CELLS
-
批准号:6744445
-
项目类别:
-
资助金额:$25.17万
-
财政年份:2002
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
OSTEOCLAST DIFFERENTIATION BY MESENCHYMAL CELLS
-
批准号:6616050
-
项目类别:
-
资助金额:$25.17万
-
财政年份:2002
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
CELLULAR MECHANISMS OF IMPLANT LOOSENING
-
批准号:2083519
-
项目类别:
-
资助金额:$22.44万
-
财政年份:1996
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
CELLULAR MECHANISMS OF IMPLANT LOOSENING
-
批准号:6055614
-
项目类别:
-
资助金额:$25.44万
-
财政年份:1996
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
CELLULAR MECHANISMS OF IMPLANT LOOSENING
-
批准号:2517502
-
项目类别:
-
资助金额:$23.89万
-
财政年份:1996
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
CELLULAR MECHANISMS OF IMPLANT LOOSENING
-
批准号:2769626
-
项目类别:
-
资助金额:$24.65万
-
财政年份:1996
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
CELLULAR MECHANISMS OF IMPLANT LOOSENING
-
批准号:6534431
-
项目类别:
-
资助金额:$26.78万
-
财政年份:1996
-
负责人:EDWARD M. GREENFIELD
-
依托单位:
海外基金